Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated July 26, 2025, titled "Revised Press Release for Unaudited Financial results for the quarter ended June 30, 2025".
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated July 26, 2025, titled "Revised Press Release for Unaudited Financial results for the quarter ended June 30, 2025".